title: Another reality check: the direct costs of providing post-exposure prophylaxis in a population-based programme.
authors.forename: P
authors.initials: P
authors.lastname: Braitstein
authors.forename: K
authors.initials: K
authors.lastname: Chan
authors.forename: A
authors.initials: A
authors.lastname: Beardsell
authors.forename: A
authors.initials: A
authors.lastname: McLeod
authors.forename: J S
authors.initials: JS
authors.lastname: Montaner
authors.forename: M V
authors.initials: MV
authors.lastname: O'Shaughnessy
authors.forename: R S
authors.initials: RS
authors.lastname: Hogg
mesh_terms: D019380:Anti-HIV Agents / Q000191:economics* / Q000627:therapeutic use; D018890:Chemoprevention / Q000191:economics; D016527:Drug Costs / Q000706:statistics & numerical data*; D011307:Drug Prescriptions / Q000191:economics; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D010349:Patient Compliance; D011795:Surveys and Questionnaires
chemical_list: D019380:Anti-HIV Agents